EUCLIDEAN CAPITAL LLC Holdings
EUCLIDEAN CAPITAL LLC is an investment fund managing more than 107.72M US dollars. The largest holdings include 23andMe Holding, PMV Pharmaceuticals and Foghorn Therapeutics. In Q1 2022 the fund bought assets of total value of 48.14M US dollars and sold assets of total value of 8.69M US dollars.
EUCLIDEAN CAPITAL LLC portfolio value:
EUCLIDEAN CAPITAL LLC quarter portfolio value change:
EUCLIDEAN CAPITAL LLC 1 year portfolio value change:
EUCLIDEAN CAPITAL LLC portfolio changes
| Period | Buy | Sel |
|---|---|---|
| Q1 2021 | 5251000 | 46405000 |
| Q2 2021 | 15543000 | 4280000 |
| Q3 2021 | 24460000 | 114104000 |
| Q4 2021 | 5940000 | 43537000 |
| Q1 2022 | 48140000 | 8694000 |
EUCLIDEAN CAPITAL LLC 13F holdings
| Stock |
|---|
| Portfolio share: 27.20% Portfolio value: 29.29M Avg. open price: N/A Current price: $3.19 P/L: N/A N/A Q1 2022 |
| Portfolio share: 25.82% Portfolio value: 27.80M Avg. open price: N/A Current price: $9.89 P/L: N/A Sold -15.63% shares Q4 2021 |
| Portfolio share: 10.05% Portfolio value: 10.82M Avg. open price: N/A Current price: $6.73 P/L: N/A N/A Q4 2020 |
| Portfolio share: 9.67% Portfolio value: 10.41M Avg. open price: N/A Current price: $16.53 P/L: N/A Sold -31.85% shares Q4 2021 |
| Portfolio share: 9.07% Portfolio value: 9.76M Avg. open price: N/A Current price: $5.6 P/L: N/A Sold -10.29% shares Q4 2021 |
| Portfolio share: 8.61% Portfolio value: 9.27M Avg. open price: N/A Current price: $8.68 P/L: N/A N/A Q4 2020 |
| Portfolio share: 3.40% Portfolio value: 3.65M Avg. open price: N/A Current price: $25.28 P/L: N/A N/A Q4 2020 |
| Portfolio share: 2.47% Portfolio value: 2.65M Avg. open price: N/A Current price: $2.42 P/L: N/A N/A Q3 2021 |
| Portfolio share: 2.22% Portfolio value: 2.39M Avg. open price: N/A Current price: $4.02 P/L: N/A Sold -3.81% shares Q4 2021 |
| Portfolio share: 1.51% Portfolio value: 1.62M Avg. open price: N/A Current price: $0.54 P/L: N/A Sold -0.00% shares Q1 2022 |
Showing TOP 10 EUCLIDEAN CAPITAL's 13F holdings.
Frequently Asked Questions (FAQ)
What is the biggest position of EUCLIDEAN CAPITAL LLC?
The biggest position of the EUCLIDEAN CAPITAL LLC is 23andMe Holding Co. (ME) with 27.2% portfolio share worth of 29.3M US dollars.
Top 5 EUCLIDEAN CAPITAL's holdings represent 81.8% of the portfolio:
- 23andMe Holding Co. (ME) – 27.2%
- PMV Pharmaceuticals, Inc. (PMVP) – 25.82%
- Foghorn Therapeutics Inc. (FHTX) – 10.05%
- RAPT Therapeutics, Inc. (RAPT) – 9.67%
- NGM Biopharmaceuticals, Inc. (NGM) – 9.07%
Who is the portfolio manager of EUCLIDEAN CAPITAL LLC?
The portfolio manager of the EUCLIDEAN CAPITAL LLC is .
What is the total asset value of the EUCLIDEAN CAPITAL LLC portfolio?
EUCLIDEAN CAPITAL LLC total asset value (portfolio value) is 107.72M US dollars.
Who is ?
is the portfolio manager of the EUCLIDEAN CAPITAL LLC.
What is (EUCLIDEAN CAPITAL LLC) fund performance?
EUCLIDEAN CAPITAL's quarterly performance is -8.39%, annualy -61.19%.
What is the EUCLIDEAN CAPITAL LLC CIK?
EUCLIDEAN CAPITAL's Central Index Key is 0001825034 .